Vero alda - Company finances
|
EUR
|
2024
From: 2024-07-09
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 11,666 | 42,154 |
| Profit before tax | 7,563 | - |
| Net profit | 7,185 | 7,105 |
| Equity | 7,186 | 14,291 |
| Liabilities | 1,324 | 24,047 |
| Non-current assets | 410 | 22,360 |
| Current assets | 8,100 | 15,978 |
| Total assets | 8,510 | 38,338 |
|
Taxes paid
|
||
| STI taxes | - | 378 |
|
Financial indicators
|
||
| Revenue change y/y | - | +261.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 84.4% | 18.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 49.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 61.6% | 16.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 64.8% | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 1.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vero alda - Social security debts
The company had no debts to Sodra
Vero alda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-16 | 2026-02-21 | 1077.75 |
| 2025-07-10 | 2025-07-20 | 0.34 |
| 2025-07-02 | 2025-07-09 | 106.53 |
| 2025-07-01 | 2025-07-01 | 379.4 |
| 2025-06-19 | 2025-06-30 | 378.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vero alda, MB (company code 306947272) is a small partnership engaged in retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €42.2K and net profit of €7.1K, which resulted in a 16.9% profit margin. Revenue increased by 261.3% year on year, reflecting a much stronger sales base than in 2024. In 2024, revenue was €11.7K and net profit was €7.2K over a 175-day period, so profitability remained broadly stable despite the sharp expansion in turnover. The balance sheet strengthened in 2025, with total assets of €38.3K, equity of €14.3K and liabilities of €24.0K. Long-term assets rose to €22.4K, while short-term assets were €16.0K. Key ratios indicate moderate leverage and solid operating efficiency, with equity ratio at 37.3%, debt-to-equity at 1.68 and asset turnover at 1.10x. Return on equity was 49.7% and return on assets 18.5%. No staff data was provided, so revenue per employee cannot be assessed.